Elevated IL-10 concentrations in serum and saliva from patients with oral lichen planus

Quintessence International

Volumn 42, Issue 2, 2011, Pages 157-163

  Dan, Hongxia ^a   Liu, Wenzhao ^a,b   Wang, Jiayi ^a   Wang, Zhiyong ^a   Wu, Ruiqing ^a   Chen, Qianming ^a   Zeng, Xin ^a   Zhou, Yu ^a  

^a SICHUAN UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Oral lichen planus; Saliva; Serum

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ASIAN; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOLOGY; LICHEN PLANUS; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; SALIVA;

ADULT; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; SALIVA; STATISTICS, NONPARAMETRIC;

EID: 79960134431     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13: 350-365.
2. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: Report of an international consensus meetin. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100: 40-51.
3. Conti P, Kempuraj D, Kandere K, et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003;86: 123-129.
4. Pestka S, Krause CD, Sarkar D, Walter MR, Shi YF, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22: 929-979.
5. Oleksyk TK, Shrestha S, Truelove AL, et al. Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun 2009;10: 309-322.
6. Chun HY, Chung JW, Kim HA, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 2007;27: 461-466.
7. Chang YH, Huang CN, Wu CY, Shiau MY. Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Human Immunol 2005;66: 1258-1263.
8. Kingo K, Koks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun 2003;4: 455-457.
9. Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2,-4,-10, tumour necrosis factor-alpha and transforming growth factorbeta mRNAs in oral lichen planus. Arch Oral Biol 1999;44: 499-507.
10. Bai JP, Lin M, Zeng X, et al. Association of polymorphisms in the human IFN-gamma and IL-4 gene with oral lichen planus: A study in an ethnic Chinese cohort. J Interferon Cytokine Res 2008;28: 351-358.
11. Lima DP, Diniz DG, Moimaz SAS, Sumida DH, Okamoto AC. Saliva: Reflection of the body. Int J Infect Dis 2010;14: e184-e188.
12. Wu JY, Yi C, Chung HR, et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 2010;46: 226-231.
13. Zhang L, Farrell JJ, Zhou H, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010;138: 949-957.
14. van der Meij EH, Schepman KP, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: A prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96: 164-171.
15. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694: 72-77.
16. Liu WZ, Dan HX, Wang Z, et al. IFN-Gamma and IL-4 in saliva of patients with oral lichen planus: A study in an ethnic Chinese population. Inflammation 2009;32: 176-181.
17. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun 2003;20: 281-285.
18. Meisel C, Vogt K, Platzer C, Randow D, Liebenthal C, Volk HD. Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression. Eur J Immunol 1996;26: 1580-1586.
19. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 1995;7: 517-523.
20. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-Review of a new approach. Pharmacol Rev 2003;55: 241-269.
21. Beebe AM, Cua DJ, de Waal Malefyi R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 2002;3: 403-412.
22. Mussi A, Bonifati C, Carducci M, et al. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids. J Biol Regul Homeost Agents 1994;8: 117-120.
23. Asadullah K, Docke WD, Ebeling M, et al. Interleukin 10 treatment of psoriasis-Clinical results of a phase 2 trial. Arch Derm 1999;135: 187-192.
24. Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103: s25-s31.
25. Sugerman PB, Savage NW. Oral lichen planus: Causes, diagnosis and management. Aust Dent J 2002;47: 290-297.
26. Zhang YY, Lin M, Zhang ST, et al. NF-kappa B-dependent cytokines in saliva and serum from patients with oral lichen planus: A study in an ethnic Chinese population. Cytokine 2008;41: 144-149.